This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 112/25/3823    most recent CIRCULATIONAHA.105.542266v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dalal, D. Articles by Calkins, H. Search for Related Content PubMed PubMed Citation Articles by Dalal, D. Articles by Calkins, H. Related Collections Myocardial cardiomyopathy disease

(Circulation. 2005;112:3823-3832.)
© 2005 American Heart Association, Inc.

Arrhythmia/Electrophysiology

Arrhythmogenic Right Ventricular Dysplasia

A United States Experience

Darshan Dalal, MD, MPH; Khurram Nasir, MD, MPH; Chandra Bomma, MD; Kalpana Prakasa, MD; Harikrishna Tandri, MD; Jonathan Piccini, MD; Ariel Roguin, MD; Crystal Tichnell, MGC; Cynthia James, PhD, ScM; Stuart D. Russell, MD; Daniel P. Judge, MD; Theodore Abraham, MD; Philip J. Spevak, MD; David A. Bluemke, MD, PhD; Hugh Calkins, MD

From the Division of Cardiology (D.D., K.N., C.B., K.P., H.T., J.P., A.R., C.T., C.J., S.D.R., D.P.J., T.A., D.A.B., H.C.), Department of Radiology (D.A.B.), and Division of Pediatric Cardiology (P.J.S.), The Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Hugh Calkins, MD, 600 N Wolfe St, Carnegie 530, Baltimore, MD 21287. E-mail hcalkins{at}jhmi.edu

Received February 15, 2005; revision received October 13, 2005; accepted October 17, 2005.

Background— Arrhythmogenic right ventricular dysplasia (ARVD) is an inherited cardiomyopathy characterized by right ventricular dysfunction and ventricular arrhythmias. The purpose of our study was to describe the presentation, clinical features, survival, and natural history of ARVD in a large cohort of patients from the United States.

Methods and Results— The patient population included 100 ARVD patients (51 male; median age at presentation, 26 [interquartile range {IQR}, 18 to 38; range, 2 to 70] years). A familial pattern was observed in 32 patients. The most common presenting symptoms were palpitations, syncope, and sudden cardiac death (SCD) in 27%, 26%, and 23% of patients, respectively. Among those who were diagnosed while living (n=69), the median time between first presentation and diagnosis was 1 (range, 0 to 37) year. During a median follow-up of 6 (IQR, 2 to 13; range, 0 to 37) years, implantable cardioverter/defibrillators (ICD) were implanted in 47 patients, 29 of whom received an appropriate ICD discharge, including 3 patients who received the ICD for primary prevention. At follow-up, 66 patients were alive, of whom 44 had an ICD in place, 5 developed signs of heart failure, 2 had a heart transplant, and 18 were on drug therapy. Thirty-four patients died either at presentation (n=23: 21 SCD, 2 noncardiac deaths) or during follow-up (n=11: 10 SCD, 1 of biventricular heart failure), of whom only 3 were diagnosed while living and 1 had an ICD implanted. On Kaplan-Meier analysis, the median survival in the entire population was 60 years.

Conclusions— ARVD patients present between the second and fifth decades of life either with symptoms of palpitations and syncope associated with ventricular tachycardia or with SCD. Diagnosis is often delayed. Once diagnosed and treated with an ICD, mortality is low. There is a wide variation in presentation and course of ARVD patients, which can likely be explained by the genetic heterogeneity of the disease.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				D. J. Callans Diagnosing Subtle Forms of Potentially Life-Threatening Diseases. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 740 - 741. [Full Text] [PDF]

				D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al. Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440. [Abstract] [Full Text] [PDF]

				D. Dalal, C. James, R. Devanagondi, C. Tichnell, A. Tucker, K. Prakasa, P. J. Spevak, D. A. Bluemke, T. Abraham, S. D. Russell, et al. Penetrance of Mutations in Plakophilin-2 Among Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1416 - 1424. [Abstract] [Full Text] [PDF]

				J.P. van Tintelen, M. M. Entius, Z. A. Bhuiyan, R. Jongbloed, A. C.P. Wiesfeld, A. A.M. Wilde, J. van der Smagt, L. G. Boven, M. M.A.M. Mannens, I. M. van Langen, et al. Plakophilin-2 Mutations Are the Major Determinant of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circulation, April 4, 2006; 113(13): 1650 - 1658. [Abstract] [Full Text] [PDF]